Table 1.
Features | Case |
---|---|
Age | |
≤ 50 | 46 (43.8%) |
> 50 | 59 (56.2%) |
Gender | |
Male | 82 (78.1%) |
Female | 23 (21.9%) |
AFP (ng/ml) | |
≤ 400 | 17 (16.2%) |
> 400 | 88 (83.8%) |
Tumor diameter (cm) | |
≤ 5 | 41 (39.1%) |
> 5 | 64 (60.9%) |
Vascular invasion | |
No | 22 (20.9%) |
Yes | 83 (79.1%) |
Edmondson | |
III–IV | 105 (100%) |
Sorafenib | |
Resistance | 29 (27.6%) |
Sensitive | 76 (72.4%) |